-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Brainstorm Cell Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2024.
- Brainstorm Cell Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 5.02M shares, a 74.9% increase year-over-year.
- Brainstorm Cell Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 5.02M shares, a 74.9% increase from 2023.
- Brainstorm Cell Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2.87M shares, a 92.1% decline from 2022.
- Brainstorm Cell Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 36.5M shares, a 0.91% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)